GLYCOMIMETICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.271 USD | -1.09% |
|
+0.37% | -88.52% |
| May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
Chart calendar GlycoMimetics, Inc.
a88317bf1f7cae8018e599fc76.2Wt1orMtS9udOMhUMlOwwbRshrHrCl1VPwqWzYkpm30.mAwD5IFDA4PMSK0TUzz8osxU1uvTTAwbdl_PuuN_6xuAIA-b5RotlsdPgQ~b5101b2279b3d68a3bf4303fe7c2f7bc
Upcoming events on GlycoMimetics, Inc.
Past events on GlycoMimetics, Inc.
| 2024-05-09 08:30 am | Q1 2024 Earnings Call |
| 2024-05-09 07:00 am | Q1 2024 Earnings Release |
| 2024-05-06 08:30 am | Uproleselan Pivotal Phase 3 Study Results Call |
| 2024-05-01 09:00 am | Annual General Meeting |
| 2024-03-27 08:30 am | Q4 2023 Earnings Call |
| 2024-03-27 07:00 am | Q4 2023 Earnings Release |
| 2024-03-04 12:50 pm | TD Cowen Health Care Conference |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Poster No: 2922 |
| 2023-12-09 08:30 pm | American Society of Hematology Meeting - Poster No: 1492 |
| 2023-11-16 08:30 am | Jefferies London Healthcare Conference |
| 2023-11-03 08:30 am | Q3 2023 Earnings Call |
| 2023-11-03 07:00 am | Q3 2023 Earnings Release |
| 2023-09-13 11:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-02 08:30 am | Q2 2023 Earnings Call |
| 2023-08-02 07:00 am | Q2 2023 Earnings Release |
| 2023-06-07 04:00 pm | Jefferies Global Healthcare Conference - Fireside Chat |
| 2023-05-19 09:00 am | Annual General Meeting |
| 2023-05-03 08:30 am | Q1 2023 Earnings Call |
| 2023-05-03 07:00 am | Q1 2023 Earnings Release |
| 2023-03-29 08:30 am | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 10,2 8,40 20.99% | 1,16 1,13 2.84% | 0,08 0,05 50% | 0,01 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -61,4 -61,8 0.7% | -51,5 -51,7 0.44% | -63,4 -63,9 0.68% | -47,4 -45,7 -3.66% | -39,3 -39,8 1.23% | -41,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -57,9 -57,2 -1.23% | -51,0 -50,7 -0.72% | -63,4 -62,2 -1.97% | -46,7 -45,9 -1.72% | -36,9 -37,4 1.34% | -44,5 |
|
Net income Million USD | Released Forecast Spread | -57,9 -57,3 -0.97% | -51,0 -50,9 -0.25% | -63,4 -63,6 0.32% | -46,7 -45,4 -2.75% | -36,9 -37,5 1.7% | -40,8 |
|
EPS USD | Released Forecast Spread | -1,34 -1,31 -2.16% | -1,12 -1,11 -0.54% | -1,23 -1,25 1.4% | -0,89 -0,87 -2.3% | -0,58 -0,60 3.73% | -0,63 |
| Announcement Date | 28/02/20 | 02/03/21 | 03/03/22 | 29/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,08 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,03 - | 0,00 0,00 - | 0,01 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 -16,2 9.44% | -13,4 -14,8 9.69% | -8,77 -14,2 38.38% | -10,6 -8,91 -19.23% | -10,9 -10,4 -5.51% | -8,93 -11,2 20.52% | -9,81 -9,27 -5.88% | -9,59 -10,1 4.79% | -11,1 -11,1 -0.14% | -10,8 | -11,4 | -10,2 | -10,7 | -12,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,7 -15,6 5.77% | -13,3 -15,1 12.14% | -8,52 -15,7 45.71% | -10,2 -9,00 -13.83% | -10,4 -11,0 5.83% | -8,26 -13,4 38.37% | -9,20 -9,40 2.1% | -9,08 -9,59 5.33% | -10,7 -11,0 2.54% | -11,4 | -11,9 | -10,3 | -10,7 | -12,7 |
|
Net income Million USD | Released Forecast Spread | -14,7 -16,0 8.35% | -13,3 -14,8 10.25% | -8,52 -14,2 40% | -10,2 -8,84 -15.89% | -10,4 -10,3 -1.04% | -8,26 -11,6 29.04% | -9,20 -9,07 -1.48% | -9,08 -9,72 6.61% | -10,7 -10,9 1.76% | -10,7 | -10,5 | -8,76 | -10,7 | -12,7 |
|
EPS USD | Released Forecast Spread | -0,28 -0,31 8.7% | -0,25 -0,29 12.28% | -0,16 -0,26 39.24% | -0,19 -0,17 -14% | -0,17 -0,17 -2% | -0,13 -0,18 29.09% | -0,14 -0,14 2.32% | -0,14 -0,15 8.2% | -0,17 -0,17 -3.03% | -0,16 | -0,17 | -0,13 | -0,15 | -0,20 |
| Announcement Date | 28/04/22 | 03/08/22 | 09/11/22 | 29/03/23 | 03/05/23 | 02/08/23 | 03/11/23 | 27/03/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for GlycoMimetics, Inc.
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLYC Stock
- Calendar GlycoMimetics, Inc.
